Flavor & device choices among people who use ENDS: Results from the PATH Study.

IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL American Journal of Preventive Medicine Pub Date : 2024-10-01 DOI:10.1016/j.amepre.2024.09.020
Maansi Bansal-Travers, Cheryl Rivard, Cristine D Delnevo, Amy Gross, Andrew Anesetti-Rothermel, Brittany Merson, Haijun Xiao, Yu-Ching Cheng, MeLisa R Creamer, Heather L Kimmel, Cassandra A Stanton, Eva Sharma, Kristie Taylor, Kristin Lauten, Maciej Goniewicz, Andrew Hyland
{"title":"Flavor & device choices among people who use ENDS: Results from the PATH Study.","authors":"Maansi Bansal-Travers, Cheryl Rivard, Cristine D Delnevo, Amy Gross, Andrew Anesetti-Rothermel, Brittany Merson, Haijun Xiao, Yu-Ching Cheng, MeLisa R Creamer, Heather L Kimmel, Cassandra A Stanton, Eva Sharma, Kristie Taylor, Kristin Lauten, Maciej Goniewicz, Andrew Hyland","doi":"10.1016/j.amepre.2024.09.020","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>In guidance published in February 2020, the FDA described their intent to prioritize enforcement against the sale of flavored cartridge-based electronic nicotine delivery systems (ENDS) except tobacco and menthol flavors. This guidance was specific to cartridge-based ENDS and did not apply to other ENDS types or e-liquids sold in the United States (U.S.). It remains unknown if use of certain types of ENDS devices and flavors changed following the publication of this guidance.</p><p><strong>Methods: </strong>This analysis includes PATH Study data from Wave 5 (W5, 2018-2019) and Wave 6 (W6, 2021) and examines cross-sectional estimates of 1) use of flavored ENDS and 2) use of different device types. All analyses in this study were stratified by self-reported age (youth - aged 12-17 years at W5 and aged 14-17 years at W6, and adults - aged 18-20, 21-24, and 25+). Analyses were conducted in 2023-2024.</p><p><strong>Results: </strong>Among adults aged 21 years and over, there were significant increases in the use of menthol or mint flavored ENDS. There were no substantial changes in flavors of ENDS used among youth or adults aged 18-20 years. Among all age groups, the use of cartridge-based ENDS was lower in 2021 than 2018-2019, with a notable shift to disposable-style ENDS.</p><p><strong>Conclusions: </strong>Federal-level tobacco control actions taken in the U.S. in early 2020 prioritized enforcement against \"any flavored, cartridge-based ENDS product (other than a tobacco- or menthol-flavored ENDS product)\". Based on this analysis, there was a shift following the policy to menthol or mint-flavored ENDS and disposable-style ENDS.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2024.09.020","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: In guidance published in February 2020, the FDA described their intent to prioritize enforcement against the sale of flavored cartridge-based electronic nicotine delivery systems (ENDS) except tobacco and menthol flavors. This guidance was specific to cartridge-based ENDS and did not apply to other ENDS types or e-liquids sold in the United States (U.S.). It remains unknown if use of certain types of ENDS devices and flavors changed following the publication of this guidance.

Methods: This analysis includes PATH Study data from Wave 5 (W5, 2018-2019) and Wave 6 (W6, 2021) and examines cross-sectional estimates of 1) use of flavored ENDS and 2) use of different device types. All analyses in this study were stratified by self-reported age (youth - aged 12-17 years at W5 and aged 14-17 years at W6, and adults - aged 18-20, 21-24, and 25+). Analyses were conducted in 2023-2024.

Results: Among adults aged 21 years and over, there were significant increases in the use of menthol or mint flavored ENDS. There were no substantial changes in flavors of ENDS used among youth or adults aged 18-20 years. Among all age groups, the use of cartridge-based ENDS was lower in 2021 than 2018-2019, with a notable shift to disposable-style ENDS.

Conclusions: Federal-level tobacco control actions taken in the U.S. in early 2020 prioritized enforcement against "any flavored, cartridge-based ENDS product (other than a tobacco- or menthol-flavored ENDS product)". Based on this analysis, there was a shift following the policy to menthol or mint-flavored ENDS and disposable-style ENDS.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
使用 ENDS 的人对口味和设备的选择:PATH 研究的结果。
导言:在 2020 年 2 月发布的指导意见中,FDA 阐述了对销售烟草和薄荷口味以外的盒装口味电子尼古丁给药系统 (ENDS) 优先执法的意图。该指南专门针对盒装ENDS,不适用于在美国销售的其他类型的ENDS或电子液体。该指南发布后,某些类型的ENDS设备和口味的使用是否发生了变化,目前仍不得而知:本分析包括第 5 波(W5,2018-2019 年)和第 6 波(W6,2021 年)的 PATH 研究数据,并检查了 1) 使用风味 ENDS 和 2) 使用不同设备类型的横截面估计值。本研究中的所有分析均按自我报告的年龄进行分层(青少年--W5 为 12-17 岁,W6 为 14-17 岁;成年人--18-20 岁、21-24 岁和 25 岁以上)。分析于 2023-2024 年进行:结果:在 21 岁及以上的成年人中,使用薄荷或薄荷味 ENDS 的人数显著增加。在 18-20 岁的青少年或成年人中,ENDS 的口味没有发生实质性变化。在所有年龄组中,2021年烟弹型ENDS的使用量低于2018-2019年,明显转向一次性型ENDS:2020 年初,美国联邦一级采取的控烟行动优先针对 "任何调味、盒装 ENDS 产品(烟草或薄荷味 ENDS 产品除外)"进行执法。根据这项分析,政策实施后,ENDS 产品已转向薄荷或薄荷味ENDS 和一次性ENDS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
American Journal of Preventive Medicine
American Journal of Preventive Medicine 医学-公共卫生、环境卫生与职业卫生
CiteScore
8.60
自引率
1.80%
发文量
395
审稿时长
32 days
期刊介绍: The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health. Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.
期刊最新文献
Chronic Opioid Use Following Implementation of Oregon's Medicaid Back Pain Policy. Clinician response to the 2021 USPSTF recommendation for colorectal cancer screening in average risk adults aged 45-49 years. Cost-effectiveness of mandating calorie labels on prepared foods in supermarkets. Disparities in tobacco smoking and risk of cardiovascular disease in people with low socioeconomic status or serious psychological distress: A simulation analysis. Factors associated with mental healthcare utilization among United States military personnel with posttraumatic stress disorder or depression symptoms.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1